Role of Programmed Death Ligand 1 in Colorectal Cancer

NCT07088341 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-07-28

No results posted yet for this study

Summary

1. \- Evaluation of diagnostic importance of soluble programmed death ligand-1 in patient with recently diagnosed as Colorectal cancer at different stages of disease .
2. Correlation of SPDL-1 level and clinco-pathological data of patients at presentation .

Conditions

  • Colo-rectal Cancer

Interventions

DIAGNOSTIC_TEST

elisa

enzyme- linked immunesorbent assay ( ELISA ) was used to measure soluble programmed death ligand-1 level

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2026-08-30
Completion
2026-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07088341 on ClinicalTrials.gov